-
Mashup Score: 8A Multicomponent Intervention to Improve Access to Kidney Transplant and Living Kidney Donation - 5 month(s) ago
This randomized clinical trial evaluates the effect of implementing a novel multicomponent intervention designed to target several barriers that prevent eligible patients from completing key steps toward receiving a kidney transplant.
Source: jamanetwork.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 3American Society of Nephrology | Member Services - Home - 5 month(s) ago
Take advantage of the benefits of ASN membership. Join ASN or renew membership online.
Source: www.asn-online.orgCategories: General Medicine News, NephrologyTweet-
In 2023, ASN experienced: ✔️ 800+ articles and podcasts from ASN publications. ✔️ 12,300+ participants in ASN #KidneyWk 2023. ✔️ 400+ hours of educational resources. ✔️ Six new Self-Assessment Programs. ✔️ Advocacy to improve kidney care. Join or renew: https://t.co/AXpBuyjI4H https://t.co/kui7K1kKxl
-
-
Mashup Score: 4
The world’s premier nephrology meeting, Kidney Week provides participants exciting and challenging opportunities to exchange knowledge, learn the latest scientific and medical advances, and listen to engaging and provocative discussions with leading experts in the field. Kidney Week On-Demand provides 200+ hours of Annual Meeting presentations.
Source: www.asn-online.orgCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 1American Society of Nephrology | Member Services - Home - 5 month(s) ago
Take advantage of the benefits of ASN membership. Join ASN or renew membership online.
Source: www.asn-online.orgCategories: General Medicine News, NephrologyTweet-
In 2023, ASN experienced: ✔️ 800+ articles and podcasts from ASN publications. ✔️ 12,300+ participants in ASN #KidneyWk 2023. ✔️ 400+ hours of educational resources. ✔️ Six new Self-Assessment Programs. ✔️ Advocacy to improve kidney care. Join or renew: https://t.co/AXpBuyjI4H https://t.co/kui7K1kKxl
-
-
Mashup Score: 4The Clinical Utility of Genetic Testing in the Diagnosis... : Journal of the American Society of Nephrology - 6 month(s) ago
alTrials.gov NCT05846113) is a single-arm, interventional, prospective, multicenter study that evaluated the utility of genetic testing with a broad, 385 gene panel (the RenasightTM test) on the diagnosis and management of adult patients with CKD recruited from 31 US-based community and academic medical centers. Patient medical history and clinical CKD diagnosis were collected at enrollment. Physician responses to questionnaires regarding patient disease categorization and management were collected before genetic testing and 1 month after the return of test results. Changes in CKD diagnosis and management after genetic testing were assessed. Results Of 1623 patients with CKD in 13 predefined clinical disease categories (ages, 18–96; median, 55 years), 20.8% (n=338) had positive genetic findings spanning 54 genes. Positive genetic findings provided a new diagnosis or reclassified a prior diagnosis in 48.8% of those patients. Physicians reported that genetic results altered the managemen
Source: journals.lww.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 26
The world’s premier nephrology meeting, Kidney Week provides participants exciting and challenging opportunities to exchange knowledge, learn the latest scientific and medical advances, and listen to engaging and provocative discussions with leading experts in the field. Kidney Week On-Demand provides 200+ hours of Annual Meeting presentations.
Source: www.asn-online.orgCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 4The Clinical Utility of Genetic Testing in the Diagnosis... : Journal of the American Society of Nephrology - 6 month(s) ago
alTrials.gov NCT05846113) is a single-arm, interventional, prospective, multicenter study that evaluated the utility of genetic testing with a broad, 385 gene panel (the RenasightTM test) on the diagnosis and management of adult patients with CKD recruited from 31 US-based community and academic medical centers. Patient medical history and clinical CKD diagnosis were collected at enrollment. Physician responses to questionnaires regarding patient disease categorization and management were collected before genetic testing and 1 month after the return of test results. Changes in CKD diagnosis and management after genetic testing were assessed. Results Of 1623 patients with CKD in 13 predefined clinical disease categories (ages, 18–96; median, 55 years), 20.8% (n=338) had positive genetic findings spanning 54 genes. Positive genetic findings provided a new diagnosis or reclassified a prior diagnosis in 48.8% of those patients. Physicians reported that genetic results altered the managemen
Source: journals.lww.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 32023 Editors’ Choice Award - 6 month(s) ago
In 2017, we established an annual celebration of articles that our editorial team designated as “Editors’ Choice” selections. The editors are delighted to recognize the articles listed below that h…
Source: ajkdblog.orgCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 9American Society of Nephrology | Kidney Week - Suggest Sesssions - 6 month(s) ago
Suggest sessions for future Kidney Week meetings.
Source: www.asn-online.orgCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 40
Ad hoc announcement pursuant to Art. 53 LR Ad hoc announcement pursuant to Art. 53 LR Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
Source: www.novartis.comCategories: General Medicine News, NephrologyTweet
Among transplant-eligible pts w/ advanced chronic kidney disease, this multicomponent intervention, which targeted many barriers to receiving a kidney transplant, did not significantly increase overall access to kidney transplantation. #KidneyWk @ASNKidney https://t.co/SRKcWXORU1